- [S(R)]-N-[(S)-(3,5-Di-tert-butyl-4-methoxyphenyl)[2-(di-tert-butylphosphino)phenyl]methyl]-2-methyl-2-propanesulfinamide,≥95%, 100mg
- [S(R)]-N-[(S)-(3,5-Di-tert-butyl-4-methoxyphenyl)[2-(di-tert-butylphosphino)phenyl]methyl]-2-methyl-2-propanesulfinamide,≥95%, 50mg
- (12a,18a)-5,6,12,12a,13,18,18a,19-Octahydro-5,6-dimethyl-13,18[1’,2′]-benzenobisbenzimidazo [1,2-b:2’,1′-d]benzo[i][2.5]benzodiazocine potassium trifl,≥95%, 500mg
- (11bS)-2,6-bis[3,5-bis(trifluoromethyl)phenyl]-N,N-bis[(1R)-1-phenylethyl]-dinaphtho[2,1-d:1’,2′-f][1,3,2]dioxaphosphepin-4-amine,97%, 50mg
- (11bR)-2,6-Diphenyl-N,N-bis[(1R)-1-phenylethyl]dinaphtho[2,1-d:1’,2′-f][1,3,2]dioxaphosphepin-4-amine,97%, 50mg
- (2R,4R)-2-(Diphenylphosphinomethyl)-4-(dicyclohexylphosphino)-N-(t-butoxycarbonyl)pyrrolidine,97%, 250mg
- 1-((11bR)-8,9,10,11,12,13,14,15-Octahydrodinaphtho[2,1-d:1’,2′-f][1,3,2]dioxaphosphepin-4-yl)azepane,97%, 100mg